Sectors

ENVB
Enveric Biosciences, Inc.
1.56
2 x 1.43
1 x 1.87
bid
ask
-
0.11
6.59%
1 @ 04:00 PM
1.58 +0.02 (1.28%)
Ytd-57.02%
1y-88.70%
1.43
day range
1.71
1.25
52 week range
17.64
Open1.66Prev Close1.67Low1.43High1.71Mkt Cap931.34K
Vol261.59KAvg Vol181.02KEPS-22.68P/E-0.07Forward P/E-0.22
Beta1.13Short Ratio0.31Inst. Own7.06%DividendN/ADiv YieldN/A
Ex Div Date04-23Earning08-1550-d Avg1.55200-d Avg3.321yr Est8.32
Income Statement
Operating Expenses1.63M
Research and Development Expense345.97K
Selling, General and Administrative Expense1.25M
Operating Income-1.63M
Interest Expense303.00
Net Income-1.63M
Net Income Common Stock-1.63M
Net Income Common Stock (USD)-1.63M
Consolidated Income-1.63M
Earnings per Basic Share-1.08
Earnings per Basic Share (USD)-1.08
Earnings per Diluted Share-1.08
Earning Before Interest & Taxes (EBIT)-1.63M
Earning Before Interest & Taxes (USD)-1.63M
Weighted Average Shares1.51M
Weighted Average Shares Diluted1.51M
Balance Sheet
Cash and Equivalents4.91M
Cash and Equivalents (USD)4.91M
Current Assets5.38M
Property, Plant & Equipment Net119.93K
Total Assets5.52M
Current Liabilities460.68K
Total Liabilities460.68K
Accumulated Retained Earnings (Deficit)-116.48M
Accumulated Other Comprehensive Income-587.06K
Shareholders Equity5.06M
Shareholders Equity (USD)5.06M
Assets Non-Current146.37K
Trade and Non-Trade Payables280.32K
Cash Flow
Depreciation, Amortization & Accretion37.24K
Net Cash Flow from Financing2.50M
Net Cash Flow / Change in Cash & Cash Equivalents231.28K
Issuance (Purchase) of Equity Shares2.50M
Net Cash Flow from Operations-2.26M
Effect of Exchange Rate Changes on Cash -15.09K
Share Based Compensation88.67K